Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 1, p. 1, doi. 10.1007/s11883-020-0820-8
- By:
- Publication type:
- Article
Works matching IS 15233804 AND DT 2020 AND VI 22 AND IP 1
Results: 6
1
2
Correction to: Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
3
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 1, p. 1, doi. 10.1007/s11883-020-0823-5
- By:
- Publication type:
- Article
4
Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 1, p. 1, doi. 10.1007/s11883-020-0819-1
- By:
- Publication type:
- Article
5
Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions.
- Published in:
- Current Atherosclerosis Reports, 2020, v. 22, n. 1, p. 1, doi. 10.1007/s11883-020-0822-6
- By:
- Publication type:
- Article
6
Correction to: Carotid Atherosclerosis in Patients with Atrial Fibrillation.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice